{"name":"Iksuda Therapeutics Ltd.","slug":"iksuda-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQWFNidmtGc2g3TmZPVXByc1FxbDBMTVZqU29rV0g3bzc3aXAtSGR4ay1VSXJjTkJhdkRjcEZFRk92b0FTbEVIN3d0OGY0c2NKTWxNWUZ5VG5FUWc5TXI4NU1yUDllQ3V2THVab1Z3djZtM2Nid3RXSEd6Mzk2VFcwR0RRRTAtWUUz?oc=5","date":"2026-04-06","type":"pipeline","source":"openPR.com","summary":"Leading Companies Reinforce Their Standing in the Topoisomerase I Inhibitors Market - openPR.com","headline":"Leading Companies Reinforce Their Standing in the Topoisomerase I Inhibitors Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVGhudTlQdmVrczBXOEY2Z3pDTmNKSWhVNXZvM3Jka1Y3VkhKMFdZYzIyaE9fb240SklNeVhWWWppRFhERWNOZ0FSQ2d6eU9zc2JaWmdqMWdkc1Nub1pXOHk5dkpGNk1kcXJkbjJBVzZGS041dkg1ODJsYUxCOGE2bkMzMzF2RUgyTlFsZXQtOFU2VFdPenk4dzBYQ0FoVl9wWnhMT1RZSm8zZw?oc=5","date":"2025-06-10","type":"deal","source":"BioWorld News","summary":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock - BioWorld News","headline":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"PR Newswire","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOM21NWGJUU3VHRnF1NzFjNk1RelV4RGVxWXVYN19jNGhVNjZIekt5YktjYTRBejRQeGE2VWd6V0RESG92eldPZms4RDlFZ0kxWmdtb0Z2ODFtR1ZTQWJCM0Nha0p4YXhoazJrdV9rYzVUVDlxTnAyVXRMOTdkeTR1S3ZyMDJ3TW4xU3lQa0pNY1dzeGt1R0E4Xy14bFlISWJkck1WRUdDMTFzOW5YOWlHalB5ZmpZcWR2dGxNNTEzbGhyUklaZWtWMG9fTWU1NGtPRWRIS3AyanphRFhaYmQtTGRIX21YNkRKYS1aUDNRbFFjWnN3Ti1GX3JOc3Y?oc=5","date":"2024-10-17","type":"pipeline","source":"PR Newswire","summary":"200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight - PR Newswire","headline":"200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBJamFZSHNhOFplTUIwWHFEbzFjTnpNNEJlSnFrY2xiWFcyMU1HblkxVk1LWkZlcm85c0ZMdTd4WlRNcVBjNUZPU1NWQ294VnRzaDZETS1naWpZUkRZblpwdVZyeC1hOUNTTkRYN0F3?oc=5","date":"2023-01-26","type":"patent","source":"KED Global","summary":"Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan - KED Global","headline":"Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9GSVZleHNuMndLTWVIZnZ4RmdCaDNBTXdSWVBEUHpEczQ0ZUppYXNKQmRVcFZPZWlWLTUyYW1mVlNoMjFzVkZEVnR2emhGSEFSYVYtQ3pHaTlHaTBIa1Q0a0Vmd3lGZFh2bVNnWXFB0gFyQVVfeXFMUFNPaGJwYXQ4Um1JcmZXWVdkNHdTUVFHZ3R3SHJET25QOTNNc1BTaUdXSVZxRlp4Y0UzMkt1T0ZlUTVuVG5BZGtkYnU5a214aHJMZGNIM19haGYwVHBHNEVlWjVsRllxbDJFNElMbWVPWUhB?oc=5","date":"2023-01-25","type":"pipeline","source":"koreabiomed.com","summary":"Celltrion becomes co-largest shareholder of Iksuda Therapeutics - koreabiomed.com","headline":"Celltrion becomes co-largest shareholder of Iksuda Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9VMVd5ckZ6Vk5DWC1ZUU91Vzd0NV9PcVpSc1BWdjZ5VDBoeGZrQ0NlRi1TeEFHRVJYNnJha09nOTZoVHlqUzdhVEVQdEQtSUNvbDN3YjRWb2FrenJxaEJKLTVpbnBBRlN3clgxd0hR?oc=5","date":"2022-12-23","type":"deal","source":"KED Global","summary":"LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn - KED Global","headline":"LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOYnh4NW5EclJVUzR2cDAtMk1INzFmN3l4ZkhYeW9aOTJZRVRlRzJ0VjdWckF4VEs3ZG00SEt0QlYxLV9naU9MU1J1a1JVcXM1cko1MzBYWVhRT0c2bUc4YWh1VGo3c1pWTXF3TXF4RHp1UGpySHpOSVR3VVZUbV9LeUNpZGZPZG1aVlFNODJad20yZkJ4bHFaU2xEd19vTkZHWjRvLWs1WG5BdFpiTDhHa21VdUE4RkNKelZCblptZklDVjFQdXZZQXc0dHB4czh0MDZhbVhYeURBS29TR0w0Mzd6ZE1FWWYxbmZ6NE9OQ2UtRTV4bGwyOXRUOFJqUGNnMEhmc3BwRHhqZS1VNUxJY01EbDJfcXZtd0FUUXhmUDlsV2hLUmc?oc=5","date":"2022-01-10","type":"pipeline","source":"Business Wire","summary":"Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences - Business Wire","headline":"Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme Fro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQb3Atck82TTM5ZU5mTGVVNDA1Y0d2Z2h0OWk2cVJyaWZRYTNSMkZqVi1ibEphZ0Z3bnlZRTBQUzF0cjYwMGRpQUdKMmh2NkIxRFBrV3RJMm84M2g5VnlxaG84RjZDNjBic1B4NGhRSUEyYWdVTHlXaG8yUlNNTnhIOVNUczBnZnp4ejNOOHF5SUhuNWtDN0w3ck1CSkZ0WVVkUGJqbEVROThieEZFc0dWc0l6anYxY0JNcUdIU090Q3JvZnp2U2tscDVudFJTTzdfc0VvYnRNcmdMaVctdkZlcy02d19Da0kyb3Z1bDloelR6OU9n?oc=5","date":"2021-11-12","type":"pipeline","source":"European Medical Journal","summary":"Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients? - European Medical Journal","headline":"Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTEJWeW9LSUZweU5EeWcyX3BwY3pGMm9USWN2dmc3NFFPQUd6Slg5djhaSllTNngyRWFVZGNoWTBiRTVpUHlnLTU1N1RqTTFNQWl2OFNuWk16NmU1eVdFeXFJTFJlM3p0UXZkRzgyYTZxVzE0RERuUDR1dzhLY0NPODVlX1MtbmVJM2JkXzZGRmsyUm8xRE5ZczRCZEh5T0FiX21xbkQtRUJOSHB6aEpROUsxamRjNE1kS2FZ?oc=5","date":"2021-07-07","type":"pipeline","source":"University of Bath","summary":"University spin-out Iksuda Therapeutics raises $47 million in latest funding round - University of Bath","headline":"University spin-out Iksuda Therapeutics raises $47 million in latest funding round","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}